RxDoctor Payments Data

Diane Smith, APRN

Nurse Practitioner · Sandy, UTNPI 1508250580

Payments from drug & device makers

$1,684in general payments, 2019–2025

Across 100 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$897
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$144
  • Boston Scientific$141
  • Nevro Corp.$121
  • AbbVie$90
  • UCB, Inc.$50
  • plus $241 from 9 others

What the payments were for

  • Food & beverage$1,684100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,684 in reported general payments places this provider in the 85th percentile of 979 nurse practitioner providers in Utah.

See all nurse practitioner providers in Utah

Medicare billing

Part B allowed, 2024
$22,627
Medicare patients
54
Services billed
287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BotoxOnabotulinumtoxina13$15,905
BelbucaBuprenorphine Hcl12$12,161
MovantikNaloxegol Oxalate23$10,638
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen220$9,023
OxycontinOxycodone Hcl12$8,559
GraliseGabapentin11$7,327
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen178$6,445
Oxycodone Hcl272$4,557
Xtampza ErOxycodone Myristate12$4,065
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl23$4,011
Morphine Sulfate ErMorphine Sulfate126$2,921
Fentanyl22$1,891
Buprenorphine Hcl50$1,863
Pregabalin66$1,848
Morphine Sulfate21$914

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$897$16,22624 claims
AbbVieBotox$90$15,90513 claims
Redhill Biopharma Inc.Movantik$14$10,63823 claims
Almatica Pharma LLCGralise$30$7,32711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 979 nurse practitioner providers in Utah.

Other nurse practitioner in Sandy

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →